propiconazole has been researched along with Granulocytic Leukemia, Chronic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sekine, T; Suzuki, K | 1 |
Ahmadi, MA; Butler, CE; Esmaeli, B; Kantarjian, HM; Kim, SK; Prieto, VG; Talpaz, M | 1 |
Lien-Gieschen, T; McMurtry, CT | 1 |
3 other study(ies) available for propiconazole and Granulocytic Leukemia, Chronic
Article | Year |
---|---|
[A patient with acute Philadelphia-chromosome-positive mixed phenotype leukemia developing ecthyma gangrenosum while undergoing combined imatinib mesylate chemotherapy].
Topics: Aged; Antineoplastic Agents; Benzamides; Ecthyma; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Orbit; Piperazines; Pseudomonas aeruginosa; Pseudomonas Infections; Pyrimidines | 2014 |
Severe periorbital edema secondary to STI571 (Gleevec).
Topics: Benzamides; Edema; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Magnetic Resonance Imaging; Male; Middle Aged; Orbit; Orbital Diseases; Piperazines; Protein-Tyrosine Kinases; Pyrimidines | 2002 |
Orbital leukemia. A treatable emergency in a geriatric patient.
Topics: Aged; Combined Modality Therapy; Diagnosis, Differential; Emergencies; Fatal Outcome; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemic Infiltration; Male; Orbit | 1995 |